Evidence map›Paper›PMID 27341631›Full record

ArticlePloS one2016

In Vivo Non-Invasive Tracking of Macrophage Recruitment to Experimental Stroke.

Marion Selt, Annette Tennstaedt, Andreas Beyrau, Melanie Nelles, Gabriele Schneider, Clemens Löwik, Mathias Hoehn

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Nanotechnology synergized immunoengineering for cancer.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2021
    Review
  2. Article
  3. Theranostics · 2018
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Marion SeltIn-vivo-NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany.
Annette TennstaedtIn-vivo-NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany.
Andreas BeyrauIn-vivo-NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany.
Melanie NellesIn-vivo-NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany.
Gabriele SchneiderIn-vivo-NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany.
Clemens LöwikDept. of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
Mathias HoehnIn-vivo-NMR Laboratory, Max Planck Institute for Metabolism Research, Cologne, Germany.
Max Planck Institute for Metabolism Research · DELeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain-infiltrating monocyte-derived macrophages are one of the key players in the local immune response after stroke. It is now widely accepted that the inflammatory response is not an exclusively destructive process. However, the underlying molecular mechanisms needed for proper regulation still remain to be elucidated. Here, we propose an in vitro labelling strategy for multimodal in vivo observation of macrophage dynamics distinguished from brain-residing microglia response. Prior to intracerebral transplantation into the striatum of recipient mice or systemic administration, monocytes and macrophages, isolated from luciferase-expressing mice, were labelled with superparamagnetic iron oxide particles. Temporo-spatial localization was monitored by magnetic resonance imaging, whereas survival of grafted cells was investigated using bioluminescence imaging. The labelling procedure of the isolated cells did not significantly influence cell characteristics and resulted in detection of as few as 500 labelled cells in vivo. Two weeks after stereotactic transplantation, the luciferase signal was sustained traceable, with approximately 18% of the original luciferase signal detectable for monocytes and about 30% for macrophages. Hypointensity in MRI of the graft appeared unaltered in spatial location. In a therapeutically relevant approach, systemic cell administration after stroke resulted in accumulation mostly in thoracic regions, as could be visualized with BLI. For detection of homing to ischemic brain tissue more cells need to be administered. Nevertheless, during parallel MRI sessions recruitment of i.v. injected cells to the lesion site could be detected by day 2 post stroke as scattered hypointense signal voids. With further increase in sensitivity, our multi-facetted labelling strategy will provide the basis for in vivo tracking and fate specification of tissue-infiltrating macrophages and their distinct role in stroke-related neuro-inflammation.

Indexed as

Cell TrackingAnimalsBrainCell SurvivalContrast MediaDisease Models, AnimalFemaleIronLuminescent MeasurementsMacrophagesMagnetic Resonance ImagingMaleMiceMice, TransgenicMonocytesSensitivity and SpecificityContrast MediaIron

Identifiers

PMID27341631
PMCPMC4920382
OpenAlexW2410991460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.